2023 in review: MBP closed $300 million in cross-border deals

In cross-border deals, only results count.

In 2023, Middle Branch Partners closed cross-border MedTech deals with total Enterprise Values exceeding $300,000,000. In turbulent M&A market conditions and with often challenging international MedTech markets, Middle Branch Partners performed again — at levels far exceeding those of its peers.

Contact us today to learn how Middle Branch Partners can help you achieve your M&A goals in 2024.